Analysis

Neonc Technologies Holdings, Inc. (NTHI) Stock Analysis

Neonc Technologies Holdings, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to NTHI.

websiteNTHI/analysis/NTHI

Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NTHI.

Stock profile

Ticker

NTHI

Asset type

Stock

Market cap

$137.1M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Neonc Technologies Holdings, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • NTHI primary listing

Latest Neonc Technologies Holdings, Inc. news

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric studies Extends NeOnc’s UAE footprint beyond NEO212 and complements ongoing U...

WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy

International Regulatory Validation Has Preceded Several Recent FDA Success Stories, Though Significant Development Risks RemainHouston, Texas--(Newsfile Corp. - June 22, 2026) ...

WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates

New Funding Structure Includes Redemption Rights, Ownership Limitations, and Conversion Floor as Investors Monitor Upcoming Clinical UpdatesHouston, Texas--(Newsfile Corp. - Jun...

NeOnc Provides Business Update and Reports Q1 2026 Financial Results

CALABASAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company advan...

NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts

CALABASAS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company focus...

Research sections

Valuation

Review valuation context for Neonc Technologies Holdings, Inc..

Future growth

Review future growth context for Neonc Technologies Holdings, Inc..

Past performance

Review past performance context for Neonc Technologies Holdings, Inc..

Financial health

Review financial health context for Neonc Technologies Holdings, Inc..

Dividend

Review dividend context for Neonc Technologies Holdings, Inc..

Management

Review management context for Neonc Technologies Holdings, Inc..

Ownership

Review ownership context for Neonc Technologies Holdings, Inc..

Other information

Review other information context for Neonc Technologies Holdings, Inc..

Community

Review community context for Neonc Technologies Holdings, Inc..